Can WeightWatchers stay relevant when everyone is on diet drugs?
GLP-1 medications could be the group’s death knell — or grant it a new lease on life
Related reading
Weight-loss drugs are bringing a new commercial reality
The reinforcing feedback loop that has long powered the food industry is being chemically switched off
WeightWatchers’ CEO on diet drugs: ‘The key is re-owning weight’
Tara Comonte is putting fat jabs at centre of a plan to steer company through bankruptcy protection
PwC will drop cover for weight-loss drugs from employee health plans
Big Four accountancy balks at high cost of medication it says has become ‘cultural phenomenon’
Are weight loss drugs killing off the business lunch?
Appetite suppressing medicines may be an unsavoury problem for restaurateurs as well as diners
Pharma just ‘scratching the surface’ of weight-loss drug market
Novo Nordisk chief estimates industry reaching only 15% of potential customers at most
The race to launch a pill for weight loss
Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of…